IRA Investment Strategies

Dyne Therapeutics has announced the pricing of its upsized $375 million public offering of common stock, marking a significant funding milestone.

• Gold IRA Markets Team
• July 22, 2026

The Teamsters union announced a landmark agreement with United Airlines, setting new standards for airline worker compensation and benefits.

• Gold IRA Markets Team
• July 22, 2026

Jushi Holdings Inc. will release its second quarter 2026 financial results on July 28, 2026, providing insight into its recent performance.

• Gold IRA Markets Team
• July 22, 2026

Clover Health Investments experiences a significant increase in international media mentions, indicating expanded global interest and coverage.

• Gold IRA Markets Team
• July 21, 2026

A detailed overview of what XFLT shareholders need to know ahead of the proxy contest, including confirmed facts, potential claims, and next steps.

• Gold IRA Markets Team
• July 19, 2026

4DMT announces favorable 2-year results from its PRISM Phase 2b clinical trial in wet AMD, indicating potential for a new treatment option.

• Gold IRA Markets Team
• July 19, 2026

Vireo Growth Inc. has finalized the acquisition of a Pennsylvania dispensary license, expanding its presence in the state’s medical cannabis market.

• Gold IRA Markets Team
• July 18, 2026

Costa Rica has announced a new initiative to export its agricultural products to millions of European consumers, boosting trade and local farmers.

• Gold IRA Markets Team
• July 18, 2026

CAMP4 Therapeutics announced an inducement grant under Nasdaq Rule 5635(c)(4), supporting its NASDAQ listing and growth plans.

• Gold IRA Markets Team
• July 18, 2026

Topicus.com Inc. announces it will release its Q2 financial results on August 10, 2024, providing investors with upcoming financial insights.

• Gold IRA Markets Team
• July 17, 2026